Results 21 to 30 of about 17,848 (124)
Literature and this study’s cytotoxicity EC50 values of the ciguatoxins P-CTX-3C, P-CTX-1, and C-CTX-1 in association with CBA-N2a. Error is represented as ± standard deviations (SD).
Jennifer R. McCall (1336932) +11 more
core +1 more source
CBA-N2a Ciguatoxin Standard Curves.
CBA-N2a standard curves for P-CTX-3C (closed circle) and P-CTX-1 (open triangle) with percent (%) viability of Neuro-2a plotted against toxin concentration (g mL-1).
Jennifer R. McCall (1336932) +11 more
core +1 more source
RBA(F) and CBA-N2a Results Comparison.
Linear regression between the ciguatoxin concentrations measured in sixty-one duplicate fish extracts using the RBA(F) and CBA-N2a.
Jennifer R. McCall (1336932) +11 more
core +1 more source
Journal of Extracellular Vesicles, Volume 7, Issue S1, April 2018.
Clotilde Théry, Kenneth Witwer
wiley +1 more source
The N2A region of titin has a unique structural configuration [PDF]
The N2A segment of titin is a main signaling hub in the sarcomeric I-band that recruits various signaling factors and processing enzymes. It has also been proposed to play a role in force production through its Ca2+-regulated association with actin ...
Sebastian Wolniak +21 more
core +1 more source
Sensitivity of N2A stable clones to GCV.
(A–L) N2A, N2A-pGFAP-HSVtk, and N2A-pCMV-HSVtk cells were treated separately with 0, 1, 5, or 10 μg/ml of GCV for 5 days, and their live-cell phase images or fluorescent images were captured.
Elizabeth Wei-Chia Luo (11250668) +2 more
core +1 more source
Biodistribution of scAAVHSC-CBA-eGFP in the brain and peripheral organs of nonhuman primates.
(A) Levels of vector genomes in the brain of animals treated with an IV dose of scAAVHSC17-CBA-eGFP (black bars), scAAVHSC15-CBA-eGFP (blue bars) or scAAVHSC7-CBA-eGFP (grey bars). (B) Levels of vector genomes within peripheral tissues of animals treated
Elizabeth Chlipala (8044256) +11 more
core +1 more source
eGFP staining in peripheral tissues of Cynomolgus macaques dosed with scAAVHSC-CBA-eGFP.
(A, E, I, M, Q) The animal received an IV dose of vehicle alone. (B, F, J, N, R) The animal received an IV dose of scAAVHSC17-CBA-eGFP. (C, G, K, O, S) The animal received an IV dose of scAAVHSC15-CBA-eGFP.
Elizabeth Chlipala (8044256) +11 more
core +1 more source
eGFP staining in the retinas of Cynomolgus macaques following IV delivery of scAAVHSC-CBA-eGFP.
(A) Animals received an IV dose of vehicle alone. (B) The animal was treated with an IV dose of scAAVHSC17-CBA-eGFP. (C) The animal was treated with an IV dose of scAAVHSC15-CBA-eGFP. (D) The animal received an IV dose of scAAVHSC7-CBA-eGFP. Tissues were
Elizabeth Chlipala (8044256) +11 more
core +1 more source
(A,B) Animal treated with an IV dose of scAAVHSC17-CBA-eGFP at 1.0 x 1014 vg/kg. (C,D) Animal treated with an IV dose of scAAVHSC15-CBA-eGFP at 0.7 x 1014 vg/kg. (E,F) Animal treated with scAAVHSC7-CBA-eGFP at 0.7 x 1014 vg/kg.
Elizabeth Chlipala (8044256) +11 more
core +1 more source

